Treatment of recurrent hepatitis C infection after liver transplantation with combination of PEG-IFN α2B and ribavirin:: An open label series

被引：0
|
作者：
Rodriguez-Luna, H
Khatib, A
Sharma, P
De Petris, G
Moss, A
Mulligan, D
Balan, V
Rakela, J
Vargas, HE
机构：
[1] Mayo Clin, Dept Transplantat Med, Phoenix, AZ USA
[2] Mayo Clin, Dept Pathol, Phoenix, AZ USA
来源：
LIVER TRANSPLANTATION | 2003年 / 9卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
23
引用
收藏
页码：C6 / C6
页数：1
相关论文
共 50 条
  • [1] Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon α2b and ribavirin:: An open-label series
    Rodriguez-Luna, H
    Khatib, A
    Sharma, P
    De Petris, G
    Williams, JW
    Ortiz, J
    Hansen, K
    Mulligan, D
    Moss, A
    Douglas, DD
    Balan, V
    Rakela, J
    Vargas, HE
    [J]. TRANSPLANTATION, 2004, 77 (02) : 190 - 194
  • [2] Preliminary results of naive combination therapy with 12kDa PEG-IFN α-2B and ribavirin in recurrent hepatitis C after liver transplantation (LT)
    Lavezzo, B
    Franchello, A
    Smedile, A
    Cocchis, D
    David, E
    Ghisetti, V
    Torrani, M
    Ricchiuti, A
    Salizzoni, M
    Rizzetto, M
    [J]. JOURNAL OF HEPATOLOGY, 2003, 38 : 42 - 42
  • [3] Recurrence of hepatitis C after liver transplantation: Results of PEG-IFN and ribavirin combination therapy
    Dumortier, J
    Scoazec, JY
    Boillot, O
    [J]. LIVER TRANSPLANTATION, 2003, 9 (06) : C44 - C44
  • [4] Peg-IFN and ribavirin treatment for recurrence of genotype 2 and 3 hepatitis C after liver transplantation
    Ackefors, Malin
    Castedal, Maria
    Dahlgard, Olav
    Verbaan, Hans
    Gjertsen, Henrik
    Wernerson, Annika
    Weiland, Ola
    [J]. INFECTIOUS DISEASES, 2015, 47 (04) : 209 - 217
  • [5] Treatment with combination of PEG IFN α-2B and ribavirin suppresses viral replication in liver transplantation recipients with recurrent HCV hepatitis
    Khatib, MA
    Arenas, JI
    Carey, E
    Moss, A
    Mulligan, D
    Ortiz, L
    Hansen, K
    Harrison, ME
    Douglas, D
    Balan, V
    Rakela, J
    Vargas, HE
    [J]. HEPATOLOGY, 2002, 36 (04) : 182A - 182A
  • [6] Plasma ribavirin concentrations during treatment of recurrent hepatitis C with peginterferon α-2b and ribavirin combination after liver transplantation
    Dumortier, J.
    Ducos, E.
    Scoazec, J. -Y.
    Chevallier, P.
    Boillot, O.
    Gagnieu, M. -C.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2006, 13 (08) : 538 - 543
  • [7] Treatment of recurrent hepatitis C after liver transplantation with Interferon alfa 2b and Ribavirin
    Zamboni, F
    Franchello, A
    Lavezzo, B
    Strignano, P
    Schellino, M
    Rizzetto, M
    Salizzoni, M
    [J]. TRANSPLANTATION, 2000, 69 (08) : S265 - S265
  • [8] Treatment of recurrent hepatitis C infection after liver transplantation: Randomized controlled trial of peg interferon alpha 2b and ribavirin vs. peg interferon alpha 2b, ribavirin and amantadine
    Nair, S
    Lipscomb, J
    Malloy, H
    Loss, G
    Cohen, A
    Eason, J
    [J]. GASTROENTEROLOGY, 2004, 126 (04) : A699 - A699
  • [9] Pegylated interferon (PEG-IFN) alfa-2b and ribavirin for recurrent hepatitis C (genotype 1) after liver transplantation: Relationship with steatosis
    Testino, Gianni
    Sumberaz, Alessandro
    Ravetti, Gianluigi
    Gentile, Raffaella
    Ansaldi, Filippo
    Icardi, Giancarlo
    [J]. DIGESTIVE AND LIVER DISEASE, 2006, 38 (11) : 864 - 865
  • [10] Treatment outcomes of acute viral hepatitis C, G 3 patients with Peg-IFN-Alpha 2b monotherapy versus Peg-IFN/ribavirin combination
    Gill, Muzaffar Lateef
    Gill, Uzma Muzaffar
    Salman, Farah
    Anwar, Neelum
    Aziz, Hafsa
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 216 - 217
12345